TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma

Jie Zhang, Pin Liu, Junyan Tao, Pan Wang, Yi Zhang, Xinhua Song, Li Che, Pavel Sumazin, Silvia Ribback, Andras Kiss, Z. Schaff, Antonio Cigliano, Frank Dombrowski, Carla Cossu, Rosa M. Pascale, Diego F. Calvisi, Satdarshan P. Monga, Xin Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Hepatoblastoma (HB) is the most common type of pediatric liver cancer. Activation of yes-associated protein (YAP) has been implicated in HB molecular pathogenesis. The transcriptional co-activator Yap regulates downstream gene expression through interaction with the TEA domain (TEAD) proteins. Nonetheless, YAP also displays functions that are independent of its transcriptional activity. The underlying molecular mechanisms by which Yap promotes HB development remain elusive. In the current study, we demonstrated that blocking TEAD function via the dominant-negative form of TEAD2 abolishes Yap-driven HB formation in mice and restrains human HB growth in vitro. When TEAD2 DNA-binding domain was fused with virus protein 16 transcriptional activation domain, it synergized with activated β-catenin to promote HB formation in vivo. Among TEAD genes, silencing of TEAD4 consistently inhibited tumor growth and Yap target gene expression in HB cell lines. Furthermore, TEAD4 mRNA expression was significantly higher in human HB lesions when compared with corresponding nontumorous liver tissues. Human HB specimens also exhibited strong nuclear immunoreactivity for TEAD4. Altogether, data demonstrate that TEAD-mediated transcriptional activity is both sufficient and necessary for Yap-driven HB development. TEAD4 is the major TEAD isoform and Yap partner in human HB. Targeting TEAD4 may represent an effective treatment option for human HB.

Original languageEnglish
Pages (from-to)1077-1090
Number of pages14
JournalAmerican Journal of Pathology
Volume189
Issue number5
DOIs
Publication statusPublished - May 1 2019

Fingerprint

Hepatoblastoma
Transcription Factors
Proteins
Gene Expression
Catenins
Gene Silencing
Liver Neoplasms
Growth
Transcriptional Activation
Protein Isoforms

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma. / Zhang, Jie; Liu, Pin; Tao, Junyan; Wang, Pan; Zhang, Yi; Song, Xinhua; Che, Li; Sumazin, Pavel; Ribback, Silvia; Kiss, Andras; Schaff, Z.; Cigliano, Antonio; Dombrowski, Frank; Cossu, Carla; Pascale, Rosa M.; Calvisi, Diego F.; Monga, Satdarshan P.; Chen, Xin.

In: American Journal of Pathology, Vol. 189, No. 5, 01.05.2019, p. 1077-1090.

Research output: Contribution to journalArticle

Zhang, J, Liu, P, Tao, J, Wang, P, Zhang, Y, Song, X, Che, L, Sumazin, P, Ribback, S, Kiss, A, Schaff, Z, Cigliano, A, Dombrowski, F, Cossu, C, Pascale, RM, Calvisi, DF, Monga, SP & Chen, X 2019, 'TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma', American Journal of Pathology, vol. 189, no. 5, pp. 1077-1090. https://doi.org/10.1016/j.ajpath.2019.01.016
Zhang, Jie ; Liu, Pin ; Tao, Junyan ; Wang, Pan ; Zhang, Yi ; Song, Xinhua ; Che, Li ; Sumazin, Pavel ; Ribback, Silvia ; Kiss, Andras ; Schaff, Z. ; Cigliano, Antonio ; Dombrowski, Frank ; Cossu, Carla ; Pascale, Rosa M. ; Calvisi, Diego F. ; Monga, Satdarshan P. ; Chen, Xin. / TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma. In: American Journal of Pathology. 2019 ; Vol. 189, No. 5. pp. 1077-1090.
@article{9e1939582be941fcb9d593fdc74eb4d1,
title = "TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma",
abstract = "Hepatoblastoma (HB) is the most common type of pediatric liver cancer. Activation of yes-associated protein (YAP) has been implicated in HB molecular pathogenesis. The transcriptional co-activator Yap regulates downstream gene expression through interaction with the TEA domain (TEAD) proteins. Nonetheless, YAP also displays functions that are independent of its transcriptional activity. The underlying molecular mechanisms by which Yap promotes HB development remain elusive. In the current study, we demonstrated that blocking TEAD function via the dominant-negative form of TEAD2 abolishes Yap-driven HB formation in mice and restrains human HB growth in vitro. When TEAD2 DNA-binding domain was fused with virus protein 16 transcriptional activation domain, it synergized with activated β-catenin to promote HB formation in vivo. Among TEAD genes, silencing of TEAD4 consistently inhibited tumor growth and Yap target gene expression in HB cell lines. Furthermore, TEAD4 mRNA expression was significantly higher in human HB lesions when compared with corresponding nontumorous liver tissues. Human HB specimens also exhibited strong nuclear immunoreactivity for TEAD4. Altogether, data demonstrate that TEAD-mediated transcriptional activity is both sufficient and necessary for Yap-driven HB development. TEAD4 is the major TEAD isoform and Yap partner in human HB. Targeting TEAD4 may represent an effective treatment option for human HB.",
author = "Jie Zhang and Pin Liu and Junyan Tao and Pan Wang and Yi Zhang and Xinhua Song and Li Che and Pavel Sumazin and Silvia Ribback and Andras Kiss and Z. Schaff and Antonio Cigliano and Frank Dombrowski and Carla Cossu and Pascale, {Rosa M.} and Calvisi, {Diego F.} and Monga, {Satdarshan P.} and Xin Chen",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.ajpath.2019.01.016",
language = "English",
volume = "189",
pages = "1077--1090",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma

AU - Zhang, Jie

AU - Liu, Pin

AU - Tao, Junyan

AU - Wang, Pan

AU - Zhang, Yi

AU - Song, Xinhua

AU - Che, Li

AU - Sumazin, Pavel

AU - Ribback, Silvia

AU - Kiss, Andras

AU - Schaff, Z.

AU - Cigliano, Antonio

AU - Dombrowski, Frank

AU - Cossu, Carla

AU - Pascale, Rosa M.

AU - Calvisi, Diego F.

AU - Monga, Satdarshan P.

AU - Chen, Xin

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Hepatoblastoma (HB) is the most common type of pediatric liver cancer. Activation of yes-associated protein (YAP) has been implicated in HB molecular pathogenesis. The transcriptional co-activator Yap regulates downstream gene expression through interaction with the TEA domain (TEAD) proteins. Nonetheless, YAP also displays functions that are independent of its transcriptional activity. The underlying molecular mechanisms by which Yap promotes HB development remain elusive. In the current study, we demonstrated that blocking TEAD function via the dominant-negative form of TEAD2 abolishes Yap-driven HB formation in mice and restrains human HB growth in vitro. When TEAD2 DNA-binding domain was fused with virus protein 16 transcriptional activation domain, it synergized with activated β-catenin to promote HB formation in vivo. Among TEAD genes, silencing of TEAD4 consistently inhibited tumor growth and Yap target gene expression in HB cell lines. Furthermore, TEAD4 mRNA expression was significantly higher in human HB lesions when compared with corresponding nontumorous liver tissues. Human HB specimens also exhibited strong nuclear immunoreactivity for TEAD4. Altogether, data demonstrate that TEAD-mediated transcriptional activity is both sufficient and necessary for Yap-driven HB development. TEAD4 is the major TEAD isoform and Yap partner in human HB. Targeting TEAD4 may represent an effective treatment option for human HB.

AB - Hepatoblastoma (HB) is the most common type of pediatric liver cancer. Activation of yes-associated protein (YAP) has been implicated in HB molecular pathogenesis. The transcriptional co-activator Yap regulates downstream gene expression through interaction with the TEA domain (TEAD) proteins. Nonetheless, YAP also displays functions that are independent of its transcriptional activity. The underlying molecular mechanisms by which Yap promotes HB development remain elusive. In the current study, we demonstrated that blocking TEAD function via the dominant-negative form of TEAD2 abolishes Yap-driven HB formation in mice and restrains human HB growth in vitro. When TEAD2 DNA-binding domain was fused with virus protein 16 transcriptional activation domain, it synergized with activated β-catenin to promote HB formation in vivo. Among TEAD genes, silencing of TEAD4 consistently inhibited tumor growth and Yap target gene expression in HB cell lines. Furthermore, TEAD4 mRNA expression was significantly higher in human HB lesions when compared with corresponding nontumorous liver tissues. Human HB specimens also exhibited strong nuclear immunoreactivity for TEAD4. Altogether, data demonstrate that TEAD-mediated transcriptional activity is both sufficient and necessary for Yap-driven HB development. TEAD4 is the major TEAD isoform and Yap partner in human HB. Targeting TEAD4 may represent an effective treatment option for human HB.

UR - http://www.scopus.com/inward/record.url?scp=85064589027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064589027&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2019.01.016

DO - 10.1016/j.ajpath.2019.01.016

M3 - Article

C2 - 30794805

AN - SCOPUS:85064589027

VL - 189

SP - 1077

EP - 1090

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -